In a phase-one human clinical trial, a pharmacist researcher has demonstrated that a new antibiotic, called Omadacycline, may be a promising tool in combating the superbug known as C diff which causes ...

Socks are better than nothing, but the best solution is simply to slip on a pair of house shoes. These are shoes worn only ...

Emerging research suggests the state of the gut microbiome in early life is linked to colorectal cancer—and that both too ...

Despite an expanding therapeutic armamentarium, remission rates in inflammatory bowel disease (IBD) appear to plateau at 30–50% after 1 year of treatment, leading to the concept of a therapeutic ...

The procedure might be trendy, but it comes with risks and doesn't address the root causes of digestive problems.

A new approach to leadership for the team at the top by Darrell Rigby, Sarah Elk and Steve Berez “Brian Johnson” is the chief executive of a major consumer-goods company that has been remarkably ...

1. Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 2.Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA Sears has received salary support as ...

Advanced therapies for ulcerative colitis have comparable efficacy and safety among older and younger patients.